Science 37 Holdings, Inc (SNCE) News
Filter SNCE News Items
SNCE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SNCE News Highlights
- SNCE's 30 day story count now stands at 3.
- Over the past 7 days, the trend for SNCE's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DEC, PEAK and PAR are the most mentioned tickers in articles about SNCE.
Latest SNCE News From Around the Web
Below are the latest news stories about SCIENCE 37 HOLDINGS INC that investors may wish to consider to help them evaluate SNCE as an investment opportunity.
Science 37 Receives Top Honors in Everest PEAK Matrix®Science 37 emerges as the only clinical trial site to be recognized as a Leader in Decentralized Clinical TrialsRESEARCH TRIANGLE PARK, N.C., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™ today announced that it has been named a Leader in the Decentralized Clinical Trials (DCT) PEAK Matrix® Assessment by the Everest Group, for the third consecutive year. The only clinical trial site to be named as a Leader in the PEAK |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start the trading week with a look at the biggest pre-market stock movers worth watching for Monday morning! |
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the Science 37 Holdings, Inc. Amended and Restated 2022 Employment Inducement Incentive Award Plan (the “Plan”). The Plan was approved by Science 37’s Board of Directors in November 2023. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Science 37’s Compensation Commit |
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37” or the “Company”), the clinical research industry-leading Metasite™, announced today that it will effect a 1-for-20 reverse stock split (“Reverse Stock Split”) of its outstanding common stock, par value $0.0001 per share (“Common Stock”), that will become effective on December 8, 2023, at 12:01 a.m., Eastern Time. Science 37’s Common Stock will continue to trade on The Nasdaq Ca |
Science 37 Holdings, Inc. (NASDAQ:SNCE) Q3 2023 Earnings Call TranscriptScience 37 Holdings, Inc. (NASDAQ:SNCE) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Greetings and welcome to the Science 37 Third Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Steve Halper from LifeSci Advisors. Thank you, Steve. You may […] |
It's Down 28% But Science 37 Holdings, Inc. (NASDAQ:SNCE) Could Be Riskier Than It LooksTo the annoyance of some shareholders, Science 37 Holdings, Inc. ( NASDAQ:SNCE ) shares are down a considerable 28% in... |
Science 37 Holdings Inc (SNCE) Reports Q3 2023 Financial ResultsGross Bookings Increase by 50.6% YoY, Net Loss Improves by 28.9% QoQ |
Science 37 Reports Third Quarter 2023 Financial ResultsRESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”), the industry-leading Metasite™, today reported its financial results for the quarter ended September 30, 2023. “Our third quarter results were highlighted by continued quarterly improvements in our key profitability metrics and cash burn rate,” stated David Coman, Chief Executive Officer of Science 37. “We look forward to a strong finish to the year and positive momentum head |
Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report third quarter 2023 financial results prior to the market open on Tuesday, November 7, 2023. The Science 37 management team will host a conference call to discuss these results on November 7, 2023, at 8:30 a.m. Eastern Time. The call can be accessed by dialing 1-877-269-7751 (toll-free domestic) or 1-201-389-0908 (international) an |
Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 ListRESEARCH TRIANGLE PARK, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, today announced that its Chief Delivery Officer, Darcy Forman, has been honored with a coveted spot on the prestigious PharmaVoice 100 list. This recognition not only underscores Darcy's leadership, it highlights the industry-wide impact of Science 37 and its positive contributions to patients, community providers, CROs, and clinical trial s |